Usana Health Sciences Inc
USNA
Market Cap$924.33M
Close$
$63.73
30.1% upside
Current Fair Value
30.1% upsideUndervalued by 30.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $924.33 Million |
|---|---|
| Enterprise Value | $597.32 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $3.2 |
| Beta | 1.0 |
| Outstanding Shares | 19,050,568 |
| Avg 30 Day Volume | 79,383 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 14.92 |
|---|---|
| PEG | -148.6 |
| Price to Sales | 1.04 |
| Price to Book Ratio | 1.88 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 6.57 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest